StockWatch
·
RENTOMOJO · Q2 FY27 · THE VERDICT

52% Growth Buried Under ₹16 Crore of One-Time Charges

Reported PAT ₹7.8 Cr dropped 63% YoY due to fire loss, deferred tax, IPO costs, and gratuity write-back totalling ~₹16 Cr. Strip those out: normalized PAT ~₹24 Cr aligns with 53% operational revenue growth and healthy cash conversion — the gap is the quarter.

Q2 FY27 resultsRENTOMOJORentomojo Ltd17 Nov 2026 · 6 min read
Reported PAT

₹7.8 Cr

-63% YoY

One-time adjustments

~₹16 Cr

fire ₹2.7 Cr + deferred tax ₹6 Cr + IPO ₹0.8 Cr + gratuity ₹1.2 Cr + other

Normalized PAT

~₹24 Cr

+52% YoY

Revenue

₹126.3 Cr

+53% YoY

On the result sheet, reported profit crashed 63% year-on-year — but the operational story is the inverse. The gap between the headline and the organic number is the quarter's real story.

Where the profit went

Reported PAT ₹7.8 Cr (6.2% NPM) is severely depressed by accounting adjustments totalling ~₹16 Crore: a fire loss of ₹2.7 Cr at one facility, deferred tax expense of ₹6 Cr (created Sept '26), IPO-related costs of ₹0.8 Cr, and a gratuity write-back reversal of ₹1.2 Cr. Adjust for these and normalized PAT is roughly ₹24 Crore. That 19% normalized margin aligns with operational revenue growth of 53% (52.8% composite: 42.5% subscribers + 45% gross items + 4.6% revenue-per-item appreciation) and OCF-to-EBITDA cash quality of 110%.

Q2 FY27 PAT bridge, ₹ Cr
08.9617.9226.887.8Reported16.2Adjustments24Normalized
One-time adjustments (fire, deferred tax, IPO costs, gratuity) total ~₹16 Cr. Normalized PAT ₹24 Cr is the clean run-rate.
Management claims vs. what holds up

Revenue from operations up 53% YoY

Supported

₹126.3 Cr delivered; subscriber growth 42.5%, gross items 45%, RPI +4.6% align with 52.8% composite

Normalized EBITDA +52.7% YoY; PAT +52% normalized

Supported

Reported EBITDA ₹38.5 Cr vs. normalized ₹58.8 Cr; PAT ~₹24 Cr normalized

Purchase displaced ₹447 Cr, 60% YoY growth

Supported

Per call: 3.8 lakh items ordered, 45% gross items growth, +4.6% RPI supports displacement narrative

Contractual revenue ₹690 Cr at Q2 end gives visibility

Supported

Explicitly mentioned; backed by ₹690 Cr of contracted rental tenures across subscriber base

What changed on this call

Capex intensity accelerated. H1 FY27 capex ₹192 Cr (net fixed assets up ₹140 Cr); prior full-year run-rate ~₹175 Cr. Management now forecasting ₹190+ Cr H1 implies full-year ₹380+ Cr, nearly 2.2x prior trajectory. Supporting aggressive market expansion, warehouse capacity (+51%), and experience stores. CFO clarified H1 is "deployment-heavy" vs. H2 "steady-state," reassuring on seasonal patterns.

Contractual revenue metric introduced. New disclosure: ₹690 Cr of contracted revenue at Q2 end. Provides forward visibility beyond quarterly bookings; aligns with subscription model's predictability thesis and de-risks near-term revenue.

Profitability narrative clarified. Reported ₹7.8 Cr PAT vs. prior Q1 FY27 fire loss impact; normalized profit closer to ₹24 Cr. Management transparent on adjustments but lack of guidance on when one-times end creates earnings visibility uncertainty through FY27.

How the street is positioned

Price action & valuation context: Stock at ₹587.4 as of 2026-11-17, down 9.91% from its all-time high ₹652 but up 20.88% off the 52-week low ₹485.95. RSI at 54.4 (neutral). Volume trend increasing. The 10% drawdown from ATH post-IPO pop, combined with rising volume, suggests cautious re-entry — market is repricing expectations upward but not at euphoric pace. Valuation reset is warranted given capex cycle uncertainty.

Ownership & institutional flows: DII ownership at 37.86% (heavy institutional backing, signal of domestic confidence). FII at only 4.77% (light overseas interest, waiting for guidance proof). Promoter at 19.74% (healthy skin in game). DII dominance suggests the story is resonating with Indian institutions, but FII underweight is telling — overseas capital is unconvinced absent FY28 guidance clarity and capex ROI evidence.

Bulk/block activity: No promoter selling visible. Oct bulk deals (AlphaGrep, QE Securities, Microcurves) show dealer/HNI rebalancing at ₹605-610 (near current levels). Sep deals show balanced buy-sell at ₹525-535. No red flag of insider dumping near ATH — management appears comfortable at current levels.

Risks, ranked by how much they should concern a holder
  • Capex cycle execution (₹190+ Cr H1 run-rate must drive 50%+ growth; if growth slows, ROC target 25% at risk)

  • Item-per-user plateau (2.8 is ceiling; management not expecting further gains; incremental value-per-user capped unless new categories scale)

  • Accounting volatility (Reported ₹7.8 Cr vs. normalized ₹24 Cr pattern suggests quarterly surprises; interim clarity poor until FY28)

  • NCLT legal matter unresolved (Dec 2026 hearing; management shielded (sub judice); impact opaque; could spike sell-off if adverse)

  • Geographic concentration (Top 5 cities = 85% revenue; tier-2 expansion will dilute margins as CAC rises in lower-penetration markets)

What to watch next
  • 1 · Q3 FY27 capex & margin payoff (Nov 2026 results)

    Does H2 capex normalize ("steady-state" vs. H1 "deployment-heavy")? Will revenue sustain 50%+ YoY without fresh capex push? Margin recovery 40-41% → 42-43% per historical H2 leverage? This is the capex cycle ROI proof.

  • 2 · Dec 2026 NCLT hearing outcome

    Legal matter resolution removes opacity overhang. Favorable verdict = re-rating on de-risking. Adverse outcome could spike sell-off despite operational health.

  • 3 · FY28 guidance (Jan-Feb 2027)

    First full-year outlook should clarify growth rate (35-53% corridor?), normalize PAT trajectory post one-times, and quantify item-per-user stance. Investors need conviction that capex cycle ROI is sustainable.

The quarter proves operational health and strong cash conversion, but accounting volatility and cautious forward tone keep sentiment guarded. The story hinges on capex cycle ROI — whether ₹190+ Cr H1 spending drives 50%+ growth sustainably or becomes a drag on ROIC. The number to track is normalized PAT, not reported: aim for ₹24 Cr+ clean run-rate by FY28 to justify current valuation and validate the capex cycle thesis.

Informational and educational content only. Not investment advice.